Open AccessPCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function
Author(s) -
Azin Kheirkhah,
Claudia Lamina,
Barbara Kollerits,
J.F. Schachtl-Rieß,
Ulla T. Schultheiss,
Lukas Forer,
Peggy Sekula,
Fruzsina Kotsis,
Kai Uwe Eckardt,
Florian Kronenberg
Publication year - 2022
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.01230122
Subject(s) - medicine , pcsk9 , renal function , disease , kidney disease , cardiology , cholesterol , ldl receptor , lipoprotein
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of lipid homeostasis. Studies investigating the association between PCSK9 and cardiovascular disease in large cohorts of patients with CKD are limited.